Deep chemical peels are commonly used by plastic surgeons to help with severely sun damaged skin, coarse wrinkles, scars, and even pre-cancerous growths. The procedure uses a chemical, Phenol, that removes the top layer of skin, causing smoother and younger looking skin to grow back. Phenol are the most aggressive type of skin peel, but can produce more dramatic results. The downside is that it involves longer recovery times. This is where hyperbaric oxygen comes into the picture. Hyperbaric therapy helps to speed up healing. In this study, patients undergoing phenol chemical peel (PCP) were divided into 2 groups. The first group had PCP only and the second group had 5 sessions of hyperbaric oxygen therapy following PCP. The Results: Hyperbaric oxygen therapy following PCP was associated with faster recovery as assessed by both patients and caregivers <view study> Read Less

Hyperbaric oxygen therapy is very well known for its positive effects in early bone healing and more importantly on its promotion of new bone growth. Now it is being more commonly used alongside dental procedures, including implants. For an implant to be successful, it ideally needs to have bone grow around it on all sides. This study was able to demonstrate that the addition of hyperbaric therapy improved bone growth following implantation. One of the key clinical benefits that was observed was that the healing time around the implants was significantly reduced. Overall, it may be a very good idea to utilize the regenerative benefits of hyperbaric oxygen therapy for patients undergoing dental surgery, particularly for those who are at greater risk for complications or failures <view study> Read Less

There have been numerous reports, medical studies, and clinical data to support the use of hyperbaric oxygen therapy (HBOT) for a vast number of liver diseases; namely, acute liver injury, nonalcoholic steatohepatitis, liver transplantation, fibrosis and cancer, especially for hepatic artery thrombosis. Review of the current literature tell us that HBOT can have a powerful effect on promoting liver regeneration. In terms of liver diseases, it seems that the key physiological benefits of HBOT are in its antioxidant and anti-inflammatory role, helping to provide protection for damaged liver tissue. The combination of extra protection (though antioxidant and anti-inflammatory support) and enhanced regeneration, make HBOT a potential valuable tool for many liver diseases.The authors of this study take a more in-depth analysis of HBOT’s role within these disease while also citing relevant studies <view study> Read Less

A prospective study analyzing 30 men who were diagnosed with ED for more than 6 months were treated with a course of 40 hyperbaric oxygen (HBOT) sessions. The results of this study showed remarkable benefits, even for those men who previously were unsuccessful in achieving erections! After HBOT, 63% of the men had none to mild erectile dysfunction. In addition, both penetration and maintenance of erections improved significantly — 24 of the 30 men (80%) reported improved erections. Furthermore, 7 participants who agreed to undergo penile perfusion MRI pre and post HBOT allowed the researchers to conclude: “HBOT reverses the basic common pathophysiology, atherosclerosis and decreased penile perfusion, responsible for most cases of ED” <view study> Read Less

Now published in the 2018 Journal of Diabetes, research confirms some of the recently noted benefits of mild hyperbaric oxygen (m-HBOT) therapy for diabetics. Specifically, in lowering fasting and non-fasting glucose, HbA1c, and triglyceride levels; all of which are important markers leading to advanced disease states associated with this diabetes. Researchers also focused on skeletal muscle activity and fibers, and found that m-HBOT was able to help the muscle’s natural ability to use oxygen (which is typically compromised in diabetics). By helping to sensitize sugar metabolism and oxygen use within the skeletal muscles, m-HBOT can provide a significant benefit for people with diabetes. It should be noted however, that this protocol provided rats with m-HBOT daily (3 hours per day) for 22 consecutive weeks (about 5 months). <view study> Read Less